- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04096404
Gene-based Personalised Diet and Physical Activity Advice on Adiposity Indices Personalised Diet and Physical Activity Advice on Adiposity Indices in University Students
September 17, 2019 updated by: St Mary's University College
A Longitudinal Study to Determine the Effect of Gene-based Personalised Diet and Physical Activity Advice on Adiposity Indices in University Students
A longitudinal study to determine the effect of gene-based personalised diet and physical activity advice on adiposity indices in university students.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
The study uses a randomised controlled design; data for all variables (participant characteristics, height, weight, body mass index (BMI), waist circumference (WC), body fat percentage (BF%), healthy eating motivation, dietary intake and physical activity) will be collected initially from participants at St Mary's University during September and October 2019.
Participants will be genotyped, stratified randomisation (based on genotype and BMI) will be used to allocate participants to three different groups (1.
Control: no advice, 2. Non genetic personalised advice: dietary and physical activity advice based on reported dietary intake and physical activity 3. Genotype- based personalised advice: dietary and physical activity advice based on genotype, reported dietary intake and physical activity.
Following allocation to groups participants in groups 2 and 3 will receive appropriate dietary and physical activity advice via email (appendix a) and all participants will complete the healthy eating motivation questionnaire for a second time.
In April/May 2020 follow up variables (smoking status, weight, BMI, WC, BF%, healthy eating motivation, dietary intake and physical activity) will be measured again.
These follow up variables will be measured every September and April/May until September 2022.
After each follow up participants in groups 2 and 3 will be resent their dietary and physical activity advice and updated information based on their reported dietary intake and physical activity.
Study Type
Interventional
Enrollment (Anticipated)
400
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 25 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
• Age 18-25 years
Exclusion Criteria:
- Pregnancy and lactation
- Chronic disease
- A history of disordered eating and following a restricted diet.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
no advice
|
|
Active Comparator: Non genetic personalised advice
dietary and physical activity advice based on reported dietary intake and physical activity
|
Following allocation to groups participants will receive appropriate dietary and physical activity advice based on their reported intake, BMI and activity via email
|
Experimental: Genotype- based personalised advice
dietary and physical activity advice based on genotype, reported dietary intake and physical activity
|
Following allocation to groups participants will receive appropriate dietary and physical activity advice based on their reported intake, BMI and activity via email
Following allocation to groups participants will receive appropriate dietary and physical activity advice based on their genotype via email
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body weight in kg
Time Frame: 3 years
|
Weight will be measured to the nearest 0.1 kg
|
3 years
|
Body fat percentage
Time Frame: 3 years
|
Body fat percentage will be measured to the nearest 0.1%
|
3 years
|
Body mass index in Kg/m2
Time Frame: 3 years
|
calculated from measured height and weight
|
3 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dietary intake
Time Frame: 3 years
|
using a four day food diary collected using a food diary and nutritional analysis app (Libro, 2018)
|
3 years
|
Physical activity
Time Frame: 3 years
|
using the Epic Physical Activity Questionnaire (EPAQ2) (Wareham et al., 2002)
|
3 years
|
Participants motivation to eat healthily
Time Frame: 3 years
|
measured using the Healthy Eating Motivation Score (Naughton et al., 2015)
|
3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
September 1, 2019
Primary Completion (Anticipated)
September 1, 2022
Study Completion (Anticipated)
September 1, 2022
Study Registration Dates
First Submitted
August 16, 2019
First Submitted That Met QC Criteria
September 17, 2019
First Posted (Actual)
September 19, 2019
Study Record Updates
Last Update Posted (Actual)
September 19, 2019
Last Update Submitted That Met QC Criteria
September 17, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SMEC_2018-19_052
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Adiposity
-
Johns Hopkins UniversityCompleted
-
Neothetics, IncCompletedSubcutaneous Abdominal AdiposityUnited States
-
University Hospital, BrestCompleted
-
University of SharjahAl Jalila FoundationCompleted
-
University Hospital, Basel, SwitzerlandRigshospitalet, DenmarkCompletedAdipositySwitzerland
-
University of Colorado, DenverNational Institute on Aging (NIA)Not yet recruitingMenopause | Aging | Adiposity | Estrogen DeficiencyUnited States
-
Pennington Biomedical Research CenterLouisiana Clinical and Translational Science CenterTerminatedAdiposity | Menopause Surgical | Estrogen DeficiencyUnited States
-
University of Southern CaliforniaTerminatedAdiposity | Obesity, AbdominalUnited States
-
Erbe Elektromedizin GmbHErbe USA IncorporatedRecruitingObesity | AdiposityUnited States
-
Fudan UniversityInner Mongolia Yili Industrial Group Co., LtdCompletedObesity | AdiposityChina
Clinical Trials on Non genetic personalised advice
-
University of ReadingCompletedDietary Habits | Dietary ModificationUnited Kingdom
-
University of ReadingCompletedDietary Habits | Dietary ModificationKuwait, United Kingdom
-
University of Auckland, New ZealandEnrolling by invitation
-
University of ReadingUnknownDietary Habits | Dietary ModificationUnited Kingdom
-
University of ReadingActive, not recruitingDiet Modification | Diet, Healthy | Diet HabitUnited Kingdom
-
University of ReadingRoyal Berkshire NHS Foundation TrustActive, not recruitingDiet Modification | Diet Habit | Cardiac EventUnited Kingdom
-
Maastricht UniversityKing's College London; State University of New York - Upstate Medical University and other collaboratorsRecruitingPsychotic Disorders | Mood Disorders | Anxiety DisordersUnited States, Germany, Netherlands, Spain, Serbia, Romania, United Kingdom
-
Queen's University, BelfastUniversity College Dublin; Harvard School of Public Health (HSPH)Active, not recruitingCardiovascular DiseasesUnited Kingdom
-
University of California, San FranciscoPatient-Centered Outcomes Research Institute; National Cancer Institute (NCI); Robert Wood Johnson Foundation and other collaboratorsRecruitingBreast Cancer | Breast Cancer Screening | Breast Carcinoma in SituUnited States
-
Scripps Translational Science InstituteMichael J. Fox Foundation for Parkinson's Research; Intel CorporationCompletedParkinson Disease | Essential Tremor